PHARMACOKINETIC STUDIES OF SANDIMMUNE NEORAL IN LIVER-TRANSPLANT RECIPIENTS

被引：3
|
作者：
ALTRAIF, I
LEVY, G
GRANT, D
机构：
[1] TORONTO HOSP,ONTARIO LIVER TRANSPLANT STUDY GRP,TORONTO,ON,CANADA
[2] UNIV WESTERN ONTARIO,UNIV HOSP,LONDON N6A 5A5,ONTARIO,CANADA
来源：
HEPATOLOGY | 1993年 / 18卷 / 04期
关键词：
D O I：
10.1016/0270-9139(93)91829-H
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A75 / A75
页数：1
相关论文
共 50 条
  • [21] Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients
    Van Buren, D
    Payne, J
    Geevarghese, S
    MacDonell, R
    Chapman, W
    Wright, JK
    Helderman, JH
    Richie, R
    Pinson, CW
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1830 - 1832
  • [22] Sandimmune-to-Neoral conversion in stable pediatric kidney transplant recipients
    Kelles, A
    Herman, J
    Tjandra-Maga, TB
    Van Damme-Lombaerts, R
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1995 - 1996
  • [23] Results of conversion from sandimmune to neoral in stable pediatric liver transplant recipients after two years
    Dunn, SP
    Falkenstein, K
    Pierson, A
    Cooney, GF
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1962 - 1963
  • [24] Conversion from Sandimmune to Neoral in renal transplant:: Functional histopathological, and pharmacokinetic changes
    Roessler, E
    Herrera, S
    Espinoza, M
    Ayala, A
    Reynolds, E
    González, F
    Espinoza, O
    Undurraga, A
    Muñoz, R
    Arcos, O
    Galaz, G
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1756 - 1757
  • [25] Comparative bioavailability of neoral and sandimmune in cardiac transplant recipients over 1 year
    Cooney, GF
    Jeevanandam, V
    Choudhury, S
    Feutren, G
    Mueller, EA
    Eisen, HJ
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1892 - 1894
  • [26] Interim analysis of study OLN-356: Neoral versus Sandimmune in US primary liver transplant recipients
    Pinson, CW
    BeauregardZollinger, L
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2234 - 2236
  • [27] Conversion from conventional Sandimmune to Neoral therapy in stable renal transplant recipients
    Lokkegaard, H
    Asmundsson, P
    Clausen, P
    Dieperink, H
    Hansen, JM
    Heaf, J
    Jensen, SB
    Kornerup, HJ
    Madsen, S
    Pedersen, EB
    Poulsen, JV
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2199 - 2201
  • [28] INFECTIONS IN LIVER-TRANSPLANT RECIPIENTS
    WINSTON, DJ
    EMMANOUILIDES, C
    BUSUTTIL, RW
    CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) : 1077 - 1089
  • [29] Case studies: Conversion from Sandimmune to Neoral in stable renal allograft recipients
    Roth, D
    Miller, J
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2219 - 2220
  • [30] Cyclosporine bioavailability of neoral and sandimmune in white and black de novo renal transplant recipients
    Pollak, R
    Wong, RL
    Chang, CT
    THERAPEUTIC DRUG MONITORING, 1999, 21 (06) : 661 - 663
12345